tradingkey.logo

ReShape Lifesciences Inc

RSLS
詳細チャートを表示
3.920USD
0.0000.00%
終値 02/06, 16:00ET15分遅れの株価
10.29M時価総額
損失額直近12ヶ月PER

ReShape Lifesciences Inc

3.920
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

本日

0.00%

5日間

0.00%

1ヶ月

0.00%

6ヶ月

+51.94%

年初来

0.00%

1年間

-94.90%

詳細チャートを表示

TradingKey 株式スコア

データが不十分なため、株式スコアは利用できません。

ReShape Lifesciences Inc ニュース

最新情報をお待ちください...

財務指標

EPS

会社から関連データがまだ開示されていません。

総売上高

会社から関連データがまだ開示されていません。

ReShape Lifesciences Incの企業情報

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
企業コードRSLS
企業名ReShape Lifesciences Inc
最高経営責任者「CEO」Mr. Paul F. Hickey
ウェブサイトhttps://www.reshapelifesciences.com/obalon/
KeyAI